TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
MittVaccin Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
3,044
|
3,168
|
2,192 |
| Financial expenses |
54
|
27
|
21 |
| Earnings before taxes |
820
|
898
|
209 |
| EBITDA |
878
|
1,112
|
416 |
| Total assets |
3,312
|
3,572
|
2,575 |
| Current assets |
3,312
|
3,554
|
2,371 |
| Current liabilities |
317
|
1,377
|
1,320 |
| Equity capital |
265
|
346
|
374 |
| - share capital |
77
|
79
|
79 |
| Employees (average) |
10
|
7
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
8.0%
|
9.7%
|
14.5% |
| Turnover per employee |
304
|
453
|
313 |
| Profit as a percentage of turnover |
26.9%
|
28.3%
|
9.5% |
| Return on assets (ROA) |
26.4%
|
25.9%
|
8.9% |
| Current ratio |
1044.8%
|
258.1%
|
179.6% |
| Return on equity (ROE) |
309.4%
|
259.5%
|
55.9% |
| Change turnover |
-17
|
970
|
-318 |
| Change turnover % |
-1%
|
44%
|
-13% |
| Chg. No. of employees |
3
|
0
|
2 |
| Chg. No. of employees % |
43%
|
0%
|
40% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.